Orchard Therapeutics (ORTX)
NASDAQ: ORTX
· Real-Time Price · USD
16.70
0.05 (0.30%)
At close: Jan 23, 2024, 10:00 PM
Orchard Therapeutics Revenue Breakdown
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Collaboration Revenue | 743K | 663K | 703K | 593K | 400K | 587K | 465K | 483K | 492K |
| Collaboration Revenue Growth | +12.07% | -5.69% | +18.55% | +48.25% | -31.86% | +26.24% | -3.73% | -1.83% | n/a |
| Product Revenue | 5.56M | 6.65M | 534K | 6.39M | 5.38M | 3.78M | 5.06M | n/a | 700K |
| Product Revenue Growth | -16.42% | +1145.51% | -91.65% | +18.90% | +42.21% | -25.26% | n/a | -100.00% | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2022 |
|---|---|
| Europe Revenue | 5.1M |
| Europe Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 11.61M | 10.99M | 11.13M | -27.59M | 11.6M | 13.73M | 13.3M | 13.55M | 13.04M | 14.26M | 14.05M | 16.23M | 12.96M | 15.66M | 20.14M | 18.53M | 14.22M | 13.67M | 10.79M | 11.95M | 7.47M | 7.42M | 4.53M |
| Selling, General, and Administrative Revenue Growth | +5.61% | -1.28% | -140.36% | -337.80% | -15.49% | +3.24% | -1.87% | +3.93% | -8.58% | +1.51% | -13.40% | +25.24% | -17.26% | -22.27% | +8.71% | +30.29% | +4.01% | +26.73% | -9.72% | +60.09% | +0.61% | +63.93% | n/a |
| Research and Development Revenue | 14.55M | 16.7M | 15.99M | -42.76M | 18.1M | 21.96M | 28.23M | 23.35M | 20.85M | 21.75M | 21.04M | 22.65M | 14.68M | 31.57M | 24.84M | 30.9M | 28.49M | 40.48M | 17.49M | 17.43M | 27.73M | 150.99M | 9.17M |
| Research and Development Revenue Growth | -12.83% | +4.39% | -137.40% | -336.19% | -17.58% | -22.20% | +20.94% | +11.99% | -4.16% | +3.40% | -7.12% | +54.30% | -53.50% | +27.11% | -19.62% | +8.44% | -29.61% | +131.40% | +0.38% | -37.16% | -81.63% | +1546.40% | n/a |
| Sales and Marketing Revenue | 775K | 933K | 838K | 895K | 927K | 1.54M | 773K | 1.59M | 1.52M | 1.05M | 1.1M | 2.87M | 1.23M | 1.84M | 2.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | -16.93% | +11.34% | -6.37% | -3.45% | -39.81% | +99.22% | -51.41% | +4.95% | +44.52% | -4.90% | -61.53% | +132.71% | -33.22% | -14.11% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |